RxDoctor Payments Data

Brianna Paesano, PA

Medical · Stamford, CTNPI 1518522176

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $113,877 of the $153,164 with a category attached, or 74.3%. Lilly USA, LLC accounts for 69.3% of it on its own, with 29 other manufacturers making up the rest. 2025 is the largest year on record at $66,115, more than ten times the $2,086 reported in 2021. Among medical clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$153,164in general payments, 2019–2025

Across 1,006 payments — averaging $152.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$106K
  • LEO Pharma Inc.$37K
  • Johnson & Johnson$3K
  • AbbVie$2K
  • Incyte Corporation$743
  • Sun Pharmaceutical Industries Inc.$741
  • plus $4K from 24 others

What the payments were for

  • Consulting fees$6,5624%
  • Speaking & faculty fees$113,87774%
  • Travel & lodging$17,09911%
  • Food & beverage$14,94210%
  • Education$6840%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$153,164 in reported general payments places this provider in the 95th percentile of 592 medical providers in Connecticut.

See all medical providers in Connecticut

Medicare billing

Part B allowed, 2024
$30,017
Medicare patients
139
Services billed
462

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate34$2,160
Triamcinolone Acetonide64$669
Ketoconazole42$592
Betamethasone Dipropionate12$346
Doxycycline Hyclate15$164
Mupirocin13$86
Hydrocortisone16$56

Paid to pharmacies, not to this prescriber.

Other medical in Stamford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →